These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28954768)

  • 1. Personalised medicine in asthma: time for action: Number 1 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.
    Chung KF
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalised medicine in interstitial lung diseases: Number 6 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.
    Kokosi MA; Margaritopoulos GA; Wells AU
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised medicine in asthma: from curative to preventive medicine.
    Guilleminault L; Ouksel H; Belleguic C; Le Guen Y; Germaud P; Desfleurs E; Leroyer C; Magnan A
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in asthma: linking phenotypes to targeted treatments.
    Chung KF
    Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
    Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
    Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.
    Dean K; Niven R
    BioDrugs; 2017 Oct; 31(5):393-408. PubMed ID: 28879503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?
    Ray A; Camiolo M; Fitzpatrick A; Gauthier M; Wenzel SE
    Physiol Rev; 2020 Jul; 100(3):983-1017. PubMed ID: 31917651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future treatment for asthma.
    Charriot J; Vachier I; Halimi L; Gamez AS; Boissin C; Salama M; Cucu-Jarjour A; Ahmed E; Bourdin A
    Eur Respir Rev; 2016 Mar; 25(139):77-92. PubMed ID: 26929425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of asthma in real life: still a valuable goal?
    Papaioannou AI; Kostikas K; Zervas E; Kolilekas L; Papiris S; Gaga M
    Eur Respir Rev; 2015 Jun; 24(136):361-9. PubMed ID: 26028647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood asthma in the new omics era: challenges and perspectives.
    Golebski K; Kabesch M; Melén E; Potočnik U; van Drunen CM; Reinarts S; Maitland-van der Zee AH; Vijverberg SJH;
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):155-161. PubMed ID: 31985545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the Management of Severe Asthma.
    Siddiqui A; Kopas L
    Methodist Debakey Cardiovasc J; 2017; 13(2):82-83. PubMed ID: 28740590
    [No Abstract]   [Full Text] [Related]  

  • 15. Adult-onset asthma: is it really different?
    de Nijs SB; Venekamp LN; Bel EH
    Eur Respir Rev; 2013 Mar; 22(127):44-52. PubMed ID: 23457164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and asthma management: analysis and potential applications.
    Richards LB; Neerincx AH; van Bragt JJMH; Sterk PJ; Bel EHD; Maitland-van der Zee AH
    Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):96-108. PubMed ID: 29389730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
    Schoettler N; Strek ME
    Chest; 2020 Mar; 157(3):516-528. PubMed ID: 31678077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalised medicine and asthma diagnostics/management.
    Wadsworth SJ; Sandford AJ
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):118-29. PubMed ID: 23212666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma: personalized and precision medicine.
    Canonica GW; Ferrando M; Baiardini I; Puggioni F; Racca F; Passalacqua G; Heffler E
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):51-58. PubMed ID: 29189350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving Concepts of Asthma.
    Gauthier M; Ray A; Wenzel SE
    Am J Respir Crit Care Med; 2015 Sep; 192(6):660-8. PubMed ID: 26161792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.